Video

Can you give clinicians a sense of how many people treated for hypothyroidism with T4 monotherapy fall into a “less than optimal outcome” category and should be considered for combination approaches, including those that might include DTE?

Can you give clinicians a sense of how many people treated for hypothyroidism with T4 monotherapy fall into a “less than optimal outcome” category and should be considered for combination approaches, including those that might include DTE?

Video

What percentage of patients who, for symptomatic reasons, have been switched from LT4 monotherapy to DTE, do you find actually improve on DTE, and what do they report?

What percentage of patients who, for symptomatic reasons, have been switched from LT4 monotherapy to DTE, do you find actually improve on DTE, and what do they report?

Video

When using LT4 monotherapy, is monitoring of TSH sufficient to guide therapy? Can you elaborate on this?

When using LT4 monotherapy, is monitoring of TSH sufficient to guide therapy? Can you elaborate on this?

Video

There is a subset of patients who don’t respond to or are dissatisfied with levothyroxine (T4) monotherapy. What percentage don’t respond to conventional therapy? Why is combination therapy with T3/T4 considered appropriate for this group?

There is a subset of patients who don’t respond to or are dissatisfied with levothyroxine (T4) monotherapy. What percentage don’t respond to conventional therapy? Why is combination therapy with T3/T4 considered appropriate for this group?

Video

How would you summarize your experience with hypothyroidism, in particular, your perspective on the current role of combination therapy with DTE?

How would you summarize your experience with hypothyroidism, in particular, your perspective on the current role of combination therapy with DTE?

Video

Can you discuss the consensus report on identifying a subset of patients with hypothyroidism who fail to achieve optimal symptomatic resolution with LT4 monotherapy; and, therefore, should be considered for combination T4/T3 combination therapy?

Can you discuss the consensus report on identifying a subset of patients with hypothyroidism who fsaol to achieve optimal symptomatic resolution with LT4 monotherapy; and, therefore, should be considered for combination T4/T3 combination therapy?

Video

Once you commit a person with hypothyroidism to combination therapy with T4/T3, how do you follow the patient? What have you observed as far as improvements in patient status and/or their perceptions about the effects of combination T4/T3 therapy?

Once you commit a person with hypothyroidism to combination therapy with T4/T3, how do you follow the patient? What have you observed as far as improvements in patient status and/or their perceptions about the effects of combination T4/T3 therapy?

Video

Can you review current ATA-consistent guidelines for specific thyroid replacement formulations initially recommended in newly diagnosed persons with hypothyroidism? Why is T4 (levothyroxine) alone usually recommended as opposed to combination T4/T3?

Can you review current ATA-consistent guidelines for specific thyroid replacement formulations initially recommended in newly diagnosed persons with hypothyroidism? Why is T4 (levothyroxine) alone usually recommended as opposed to combination T4/T3?

Video

What is your approach to the patient who has a TSH of 2.5—well within the normal range—but the patient still has symptoms? Is there a rationale for bringing the TSH down to, let’s say, 1. 0 or 0.7, that is, to a lower level within the normal range?

What is your approach to the patient who has a TSH of 2.5—well within the normal range—but the patient still has symptoms? Is there a rationale for bringing the TSH down to, let’s say, 1. 0 or 0.7, that is, to a lower level within the normal range?